Suven Pharma consolidated Q2 net up 31 pc at Rs 97 cr
The company had reported a net profit of Rs 74 crore in the July-September period of the previous fiscal.
The Hyderabad-based company primarily operates in the contract development and manufacturing operations (CDMO) segment. Source: Twitter